HAASER CHARLES B (VP Fin & Chief Accting Officer) purchased 54.1% of their position (2.40K shares) of YIELD10 BIOSCIENCE, INC. on the open market
Open‑market purchase worth $10.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/7/2021ACC: 0001179110-21-010642
Officer· VP Fin & Chief Accting Officer
Since Apr 2019
+2.40K
Net shares
Net buyer
$10.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.40K
Price / share
$4.20
Trade value
$10.08K
% of position
54.1%
12/3/2021
4.44K→6.84K
Total
Net shares
+2.40K
Net value
$10.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/3/2021 | P · Purchase | +2.40K | $4.20 | $10.08K | 54.1% | 4.44K | 6.84K |
| Total | +2.40K | $10.08K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned4.48K
Total
4.48K indirect4.48K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.48K | Indirect |
| Total | 4.48K | 4.48K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported